SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,752.17 288.75
(0.60%)

Dow Jones

6,952.35 21.56
(0.31%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

100.5174369

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

44.47

42092.32

EPS(TTM)

Face Value()

Div & Yield %

55.87

2.17

Back

aastamangalam finance ltd

Divi's Laboratories standalone net profit rises 34.36% in the September 2025 quarter

Nov 07,2025

Net profit of Divi's Laboratories rose 34.36% to Rs 696.00 crore in the quarter ended September 2025 as against Rs 518.00 crore during the previous quarter ended September 2024. Sales rose 15.55% to Rs 2660.00 crore in the quarter ended September 2025 as against Rs 2302.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2660.00	2302.00	16
OPM %	33.65	31.67	-
PBDT	1033.00	833.00	24
PBT	920.00	735.00	25
NP	696.00	518.00	34

85,041.45 -367.25 ( -0.43%)

48,752.17 288.75 (0.60%)

6,952.35 21.56 (0.31%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)